Informed consent was obtained from all individual participants included in the study. Kostopoulos contributed equally to this work. Impact of Minimal Residual Disease Detection by Next-Generation Flow Cytometry in Multiple Myeloma Patients with Sustained Complete Remission after Frontline Therapy. e-mail: ).Ĭitation: Terpos E, Kostopoulos IV, Kastritis E, Ntanasis-Stathopoulos I, Migkou M, Rousakis P, Argyriou AT, Kanellias N, Fotiou D, Eleutherakis-Papaiakovou E, Gavriatopoulou M, Ziogas DC, Papanota AM, Spyropoulou-Vlachou M, Trougakos IP, Tsitsilonis OE, Paiva B, Dimopoulos MA.
1Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, GreeceĢDepartment of Biology, National and Kapodistrian University of Athens, School of Science, Athens, GreeceģImmunology Laboratory, Alexandra General Hospital, Athens, GreeceĤClinica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), IDISNA, CIBERONC Pamplona, SpainĬorrespondence: Evangelos Terpos (.
0 kommentar(er)
